Role of B Lymphocytes In HIV Infection And Pathogenesis
B 淋巴细胞在 HIV 感染和发病机制中的作用
基本信息
- 批准号:7732537
- 负责人:
- 金额:$ 62.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AddressAdjuvantAntibody FormationAntigensApoptosisB-LymphocytesBloodCell CountCell physiologyClinicalCommunicable DiseasesComplement 3d ReceptorsComplement ReceptorDNADefectDiseaseExhibitsGoalsHIVHIV InfectionsHomingHumanImmune responseImmunocompromised HostImmunoglobulin Somatic HypermutationImmunoglobulinsImmunologyIn VitroIndividualInterleukin-7JournalsLeadLigand BindingMS4A1 geneMedicineMemory B-LymphocyteOligonucleotidesPan GenusPathogenesisPreparationPublishingReportingRoleSafetySpecimenStimulusT-LymphocyteTLR9 geneTissuesTonsilVaccinesVirusadhesion receptorantiretroviral therapycytokineexhaustionimprovedin vivonovelperipheral bloodreceptorresponse
项目摘要
Over the past year we have pursued studies on B cells in the setting of HIV disease by focusing on 1) mechanisms of immature/transitional B-cell expansion in HIV disease; 2) responses of B-cell subpopulations to stimulation with CpG-containing oligonucleotides; 3) changes in B-cell counts and subpopulations that occur following initiation of antiretroviral therapy (ART); and 4) evidence of HIV-associated B-cell exhaustion in HIV-viremic individuals. In the first study addressing mechanisms of immature/transitional B-cell expansion in the setting of HIV disease, we investigated changes in B-cell subpopulations that occurred in the peripheral blood of HIV-infected individuals who received IL-7 as part of a large clinical safety trial. Our findings indicate that IL-7 itself can lead to the expansion of immature/transitional B cells in the peripheral blood. This is a novel observation given that a direct role for IL-7 on human B cells has never been established in vivo.
In the second study, published in The Journal of Immunology, we investigated the effect of the DNA oligonucleotide CpG-B, a ligand that binds toll-like receptor 9 expressed on B cells, on the proliferation and effector function of naive and memory B cells isolated from HIV-infected individuals. Overall, our findings indicate that CpG-B, which is currently being considered as an adjuvant in vaccine preparations aimed at augmenting immune responses in immunocompromised individuals, was effective at enhancing the proliferation and secretion of immunoglobulins and cytokines of B cells isolated from HIV-viremic and HIV-aviremic individuals. While certain defects were observed in the memory B-cell compartment of HIV-viremic individuals, nave B cells from both HIV-viremic and HIV-aviremic individuals responded robustly to CpG-B, suggesting that the presence of CpG-B in vaccines could help nave B cells reach the threshold required to productively respond to immunogens.
In the third study, published in The Journal of Infectious Diseases, we demonstrate that the over-expression of aberrant B-cell subpopulations, including immature/transitional and hyper-activated B cells, in HIV-infected individuals with active disease is reversed with effective ART. Effective ART also leads to a normalization of B-cell counts, suggesting that ongoing HIV replication is associated with a net loss of B cells, possibly through mechanisms such as increased intrinsic and extrinsic apoptosis, both of which we have previously reported.
In the fourth study, published in The Journal of Experimental Medicine, we describe evidence of HIV-associated B-cell exhaustion in an abnormal B-cell compartment that is expanded in the peripheral blood of HIV-infected viremic individuals. This B-cell subpopulation, termed tissue-like memory B cells as a result of their similarities with a recently described tonsillar memory B-cell subpopulation bearing immunoregulatory features, can be distinguished from other B cells by its high expression of the pan B-cell marker CD20 and low expression levels of the complement receptor CD21 and CD27, a classic marker of B-cell memory. Tissue-like memory B cells present in the blood of HIV-viremic individuals exhibit numerous signs of B-cell exhaustion, including increased expression of multiple inhibitory receptors; an altered expression of homing and adhesion receptors similar to that observed with virus-induced T-cell exhaustion; stunted in vivo replication and somatic hypermutation; reduced in vitro proliferation in response to B-cell stimuli; and enrichment of HIV-specific but not nonspecific and recall antigen-specific responses. These findings add to our understanding of why HIV-infected individuals mount a poor antibody response against HIV.
在过去的一年里,我们对B细胞在HIV疾病背景下的研究进行了重点关注:1)未成熟/过渡B细胞在HIV疾病中的扩增机制;2) b细胞亚群对含cpg寡核苷酸刺激的反应;3)开始抗逆转录病毒治疗(ART)后发生的b细胞计数和亚群变化;4) hiv病毒血症个体中存在与hiv相关的b细胞衰竭的证据。在研究HIV疾病背景下未成熟/过渡b细胞扩增机制的第一项研究中,我们调查了接受IL-7治疗的HIV感染者外周血中b细胞亚群的变化,这是一项大型临床安全性试验的一部分。我们的研究结果表明,IL-7本身可以导致外周血中未成熟/过渡B细胞的扩增。这是一个新的观察结果,因为IL-7对人B细胞的直接作用从未在体内建立。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells.
- DOI:10.1084/jem.192.5.637
- 发表时间:2000-09-04
- 期刊:
- 影响因子:0
- 作者:Moir S;Malaspina A;Li Y;Chun TW;Lowe T;Adelsberger J;Baseler M;Ehler LA;Liu S;Davey RT Jr;Mican JA;Fauci AS
- 通讯作者:Fauci AS
Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.
- DOI:10.1084/jem.20032236
- 发表时间:2004-09-06
- 期刊:
- 影响因子:0
- 作者:Moir S;Malaspina A;Pickeral OK;Donoghue ET;Vasquez J;Miller NJ;Krishnan SR;Planta MA;Turney JF;Justement JS;Kottilil S;Dybul M;Mican JM;Kovacs C;Chun TW;Birse CE;Fauci AS
- 通讯作者:Fauci AS
Continuous flow leukapheresis induces expression of stress genes in lymphocytes: impact on microarray analyses.
连续流白细胞分离术诱导淋巴细胞中应激基因的表达:对微阵列分析的影响。
- DOI:10.1182/blood-2003-08-2844
- 发表时间:2003
- 期刊:
- 影响因子:20.3
- 作者:Moir,Susan;Donoghue,EileenT;Pickeral,OxanaK;Malaspina,Angela;Planta,MarieA;Chun,Tae-Wook;Krishnan,SurekhaR;Kottilil,Shyamasundaran;Birse,CharlesE;Leitman,SusanF;Fauci,AnthonyS
- 通讯作者:Fauci,AnthonyS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anthony S. Fauci其他文献
Thoracic Mass Lesions in Immuno-incompetent Patients
- DOI:
10.1378/chest.82.2.164 - 发表时间:
1982-08-01 - 期刊:
- 影响因子:
- 作者:
Michael R. Johnston;Phillip A. Pizzo;Anthony S. Fauci - 通讯作者:
Anthony S. Fauci
Diadenosine 5‘,5“‘-<em>p</em>,<em>p</em><sup>4</sup>-Tetraphosphate Deficiency in Blood Platelets of the Chédiak-Higashi Syndrome
- DOI:
10.1182/blood.v66.3.735.735 - 发表时间:
1985-09-01 - 期刊:
- 影响因子:
- 作者:
Byung K. Kim;Francis C. Chao;Randi Leavitt;Anthony S. Fauci;Kenneth M. Meyers;Paul C. Zamecnik - 通讯作者:
Paul C. Zamecnik
RNA vaccines: A transformational advance.
RNA 疫苗:革命性的进步。
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:32.4
- 作者:
Brian D. Brown;Anthony S. Fauci;Y. Belkaid;M. Merad - 通讯作者:
M. Merad
Re-emergence of HIV after stopping therapy
停止治疗后艾滋病病毒的再次出现
- DOI:
10.1038/44755 - 发表时间:
1999-10-28 - 期刊:
- 影响因子:48.500
- 作者:
Tae-Wook Chun;Richard T. Davey;Delphine Engel;H. Clifford Lane;Anthony S. Fauci - 通讯作者:
Anthony S. Fauci
Anthony S. Fauci的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anthony S. Fauci', 18)}}的其他基金
Role Of Hiv Disease In The Pathogenesis Of Hepatitis B
艾滋病毒疾病在乙型肝炎发病机制中的作用
- 批准号:
6507015 - 财政年份:
- 资助金额:
$ 62.17万 - 项目类别:
Role Of Hiv Envelope Protein In Replication/Pathogenesis
HIV包膜蛋白在复制/发病机制中的作用
- 批准号:
6507017 - 财政年份:
- 资助金额:
$ 62.17万 - 项目类别:
Role Of Innate Immunity In The Initiation And Pathogenes
先天免疫在起始和病原体中的作用
- 批准号:
6986990 - 财政年份:
- 资助金额:
$ 62.17万 - 项目类别:
Interaction of HIV envelope with cell surface receptors
HIV 包膜与细胞表面受体的相互作用
- 批准号:
8946348 - 财政年份:
- 资助金额:
$ 62.17万 - 项目类别:
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
病毒库在 HIV 疾病发病机制中的作用
- 批准号:
8745373 - 财政年份:
- 资助金额:
$ 62.17万 - 项目类别:
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
病毒库在 HIV 疾病发病机制中的作用
- 批准号:
9161520 - 财政年份:
- 资助金额:
$ 62.17万 - 项目类别:
Dendritic Cell and Natural Killer Cell Interactions in H
H 中树突状细胞和自然杀伤细胞的相互作用
- 批准号:
7313454 - 财政年份:
- 资助金额:
$ 62.17万 - 项目类别:
Interaction of HIV envelope with cell surface receptors
HIV 包膜与细胞表面受体的相互作用
- 批准号:
8555852 - 财政年份:
- 资助金额:
$ 62.17万 - 项目类别:
Identification And Characterization Of Immunogenic Epito
免疫原性表位的鉴定和表征
- 批准号:
6669708 - 财政年份:
- 资助金额:
$ 62.17万 - 项目类别:
Interaction of HIV envelope with cell surface receptors
HIV 包膜与细胞表面受体的相互作用
- 批准号:
7964440 - 财政年份:
- 资助金额:
$ 62.17万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 62.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 62.17万 - 项目类别:
Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 62.17万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 62.17万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 62.17万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 62.17万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 62.17万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 62.17万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 62.17万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 62.17万 - 项目类别:














{{item.name}}会员




